Serum Institute Seeks Indemnity, Says "Same Rules For All": Sources

The government has so far not given any manufacturer indemnity or protection against legal action for any severe side effects.

After Pfizer and Moderna, Covishield-maker Serum Institute of India (SII) has asked for indemnity from liability, according to sources. All vaccine makers, whether Indian or foreign, should be granted the same protection, the Adar Poonawalla-led company has reportedly told the government. "Not just Serum Institute of India (SII), all the vaccine companies should get indemnity protection against liabilities if foreign companies are granted it," Serum sources said today, adding that rules should be the same for everyone. The government has so far not given any manufacturer indemnity or protection against legal action for any severe side effects. This is a key condition put forth by foreign vaccine-makers Pfizer and Moderna for supplying to India.